Advanced search
Publication Cover
Redox Report
Communications in Free Radical Research
Volume 25, 2020 - Issue 1
Submit an article Journal homepage
832
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Effects of α subunit substitutions on the oxidation of βCys93 and the stability of sickle cell hemoglobin

Wayne Hicksa Laboratory of Biochemistry and Vascular Biology, Center for Biologics Evaluation and Research, Food and Drug Administration (FDA), Silver Spring, Maryland, USA
,
Fantao Mengb Hemoglobin Oxygen Therapeutics, Souderton, Pennsylvania, USA
,
Tigist Kassaa Laboratory of Biochemistry and Vascular Biology, Center for Biologics Evaluation and Research, Food and Drug Administration (FDA), Silver Spring, Maryland, USA
&
Abdu I. Alayasha Laboratory of Biochemistry and Vascular Biology, Center for Biologics Evaluation and Research, Food and Drug Administration (FDA), Silver Spring, Maryland, USACorrespondence[email protected]
Pages 95-103 | Published online: 15 Oct 2020

References

  • Eaton WA, Bunn HF. Treating sickle cell disease by targeting HbS polymerization. Blood. 2017;129(20):2719–2726.
  • Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med. 1997;337(11):762–769.
  • Hebbel RP, Morgan WT, Eaton JW, et al. Accelerated autoxidation and heme loss due to instability of sickle hemoglobin. Proc Natl Acad Sci USA. 1988;85(1):237–241.
  • Jia Y, Buehler PW, Boykins RA, et al. Structural basis of peroxide-mediated changes in human hemoglobin: a novel oxidative pathway. J Biol Chem. 2007;282(7):4894–4907.
  • Kassa T, Jana S, Strader MB, et al. Sickle cell hemoglobin in the ferryl state Promotes betaCys-93 oxidation and Mitochondrial Dysfunction in Epithelial Lung cells (E10). J Biol Chem. 2015;290(46):27939–27958.
  • Belcher JD, Chen C, Nguyen J, et al. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood. 2014;123(3):377–390.
  • Jana S, Strader MB, Meng F, et al. Hemoglobin oxidation-dependent reactions promote interactions with band 3 and oxidative changes in sickle cell-derived microparticles. JCI Insight. 2018;3(21.
  • Strader MB, Jana S, Meng F, et al. Post-translational modification as a response to cellular stress induced by hemoglobin oxidation in sickle cell disease. Sci Rep. 2020;10(1):14218.
  • Meng F, Kassa T, Strader MB, et al. Substitutions in the beta subunits of sickle-cell hemoglobin improve oxidative stability and increase the delay time of sickle-cell fiber formation. J Biol Chem. 2019;294(11):4145–4159.
  • Tam MF, Tam TC, Simplaceanu V, et al. Sickle cell hemoglobin with mutation at alphaHis-50 has improved olubility. J Biol Chem. 2015;290(35):21762–21772.
  • Rhoda MD, Blouquit Y, Caburi-Martin J, et al. Effects of the alpha 20 mutation on the polymerization of Hb S. Biochim Biophys Acta. 1984;786(1-2):62–66.
  • Meng F, Alayash AI. Determination of extinction coefficients of human hemoglobin in various redox states. Anal Biochem. 2017;521:11–19.
  • Hargrove MS, Singleton EW, Quillin ML, et al. His64(E7)–>Tyr apomyoglobin as a reagent for measuring rates of hemin dissociation. J Biol Chem. 1994;269(6):4207–4214.
  • Sereda TJ, Mant CT, Sonnichsen FD, et al. Reversed-phase chromatography of synthetic amphipathic alpha-helical peptides as a model for ligand/receptor interactions. effect of changing hydrophobic environment on the relative hydrophilicity/hydrophobicity of amino acid side-chains. J Chromatogr A. 1994;676(1):139–153.
  • Milac TI, Randolph TW, Wang P. Analyzing LC-MS/MS data by spectral count and ion abundance: two case studies. Stat Interface. 2012;5(1):75–87.
  • Lundgren DH, Han DK, Eng JK. Protein identification using TurboSEQUEST. Curr Protoc Bioinformatics. 2005;Chapter 13:Unit 13 3.
  • Ikawa Y, Miccio A, Magrin E, et al. Gene therapy of hemoglobinopathies: progress and future challenges. Hum Mol Genet. 2019;28(R1):R24–R30.
  • Pawliuk R, Westerman KA, Fabry ME, et al. Correction of sickle cell disease in transgenic mouse models by gene therapy. Science. 2001;294(5550):2368–2371.
  • Strader MB, Alayash AI. Exploring oxidative reactions in hemoglobin variants using mass spectrometry: lessons for engineering oxidatively stable oxygen therapeutics. Antioxid Redox Signal. 2017;26(14):777–793.
  • Kassa T, Strader MB, Nakagawa A, et al. Targeting betaCys93 in hemoglobin S with an antisickling agent possessing dual allosteric and antioxidant effects. Metallomics. 2017;9(9):1260–1270.
  • Pimenova T, Pereira CP, Gehrig P, et al. Quantitative mass spectrometry defines an oxidative hotspot in hemoglobin that is specifically protected by haptoglobin. J Proteome Res. 2010;9(8):4061–4070.
  • Kettisen K, Strader MB, Wood F, et al. Site-directed mutagenesis of cysteine residues alters oxidative stability of fetal hemoglobin. Redox Biol. 2018;19:218–225.
  • Reeder BJ. The redox activity of hemoglobins: from physiologic functions to pathologic mechanisms. Antioxid Redox Signal. 2010;13(7):1087–1123.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.